New frontiers in CNS

Session 1: From target selection to small molecules design

This first session will cover CNS challenges in drug discovery, showcasing medicinal and computational chemistry case studies, across a range of modalities and target classes, as well as covering more general topics of relevance to scientists. Focus will be on overcoming the most common issues when dealing with CNS drug design, and exploration of innovative and advanced scientific achievements in the treatment of neurological disorders. The meeting aims to be interactive, and the event will offer excellent scientific and networking opportunities for all those working in early stages drug discovery.

When

📆 April, 29th at 04PM (CET) / 10AM (EDT)

Discussion Panel

Marco De Vivo

Istituto Italiano di TecnologĂ­a

Group Leader

Maria Laura Bolognesi

University of Bologna

Full Professor

Stephen Penrose

Anima Biotech

Research Scientist, Medicinal Chemistry

Webinar topics

  • Etymology of brain disorders for target selection
  • Design and optimization of small molecule targeting CNS
  • In vitro <-> In vivo transferability of activity, potency and efficacy
  • Multi-target approach for CNS new potential drugs
  • Targeting RNA with small molecules in the neuronal cells